TCS / Software / LIME
Roadmap to Adoption
– The FDA’s Center for Devices and Radiological Health (CDRH) granted MIRD237 a Breakthrough Device designation in 2025, citing its potential to improve safety and efficacy of radiopharmaceutical therapies. mird237 new